METTL3 and inflammatory bowel disease: In inflammatory bowel disease, aberrant expression of METTL3, YTHDC1, and other modifiers in macrophages affects their polarization states, barrier-repair capacity, and inflammatory responses, positioning them as critical regulators of immune homeostasis.